Biology Reference
In-Depth Information
Whitaker CM, Wei H (2009) An alternate cAMP pathway Epac promotes hippocampal long-term
depression. J Physiol 587:3067-3068
Wong ML, Whelan F, Deloukas P, Whittaker P, Delgado M, Cantor RM, McCann SM, Licinio J
(2006) Phosphodiesterase genes are associated with susceptibility to major depression and
antidepressant treatment response. Proc Natl Acad Sci USA 103:15124-15129
Woolfrey KM, Srivastava DP, Photowala H, Yamashita M, Barbolina MV, Cahill ME, Xie Z,
Jones KA, Quilliam LA, Prakriya M, Penzes P (2009) Epac2 induces synapse remodeling and
depression and its disease-associated forms alter spines. Nat Neurosci 12:1275-1284
Wu AY, Tang XB, Martinez SE, Ikeda K, Beavo JA (2004) Molecular determinants for cyclic
nucleotide binding to the regulatory domains of phosphodiesterase 2A. J Biol Chem 279:
37928-37938
Wunder F, Tersteegen A, Rebmann A, Erb C, Fahrig T, Hendrix M (2005) Characterization of the
first potent and selective PDE9 inhibitor using a cGMP reporter cell line. Mol Pharmacol 68:
1775-1781
Xie Z, Adamowicz WO, Eldred WD, Jakowski AB, Kleiman RJ, Morton DG, Stephenson DT,
Strick CA, Williams RD, Menniti F (2006) Cellular and subcellular localization of PDE10A, a
striatum-enriched phosphodiesterase. Neuroscience 139:597-607
Yang G, McIntyre KW, Townsend RM, Shen HH, Pitts WJ, Dodd JH, Nadler SG, McKinnon M,
Watson AJ (2003) Phosphodiesterase 7A-deficient mice have functional T cells. J Immunol
171:6414-6420
Yuasa K, Kanoh Y, Okumura K, Omori K (2001) Genomic organization of the human phosphodi-
esterase PDE11A gene, Evolutionary relatedness with other PDEs containing GAF domains.
Eur J Biochem 268:168-178
Zaccolo M, Movsesian MA (2007) cAMP and cGMP signaling cross-talk: role of phosphodies-
terases and implications for cardiac pathophysiology. Circ Res 100:1569-1578
Zhan Y, Zhang HT, O'Donnel JM (2003) Antidepressant-induced increase in high-affinity
rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function.
J Pharmacol Exp Ther 307:246-253
Zhang HT (2009) Cyclic AMP-specific phosphodiesterase-4 as a target for the development of
antidepressant drugs. Curr Pharm Des 15:1687-1698
Zhang HT, O'Donnell JM (2000) Effects of rolipram on scopolamine-induced impairment of
working and reference memory in the radial-arm maze tests in rats. Psychopharmacology 150:
311-316
Zhang HT, Crissman AM, Dorairaj NR, Chandler LJ, O'Donnell JM (2000) Inhibition of cyclic
AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor
antagonism. Neuropsychopharmacology 23:198-204
Zhang HT, Huang Y, Jin SL, Frith SA, Suvarna N, Conti M, O'Donnell JM (2002a)
Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient
in the
PDE4D phosphodiesterase enzyme. Neuropsychopharmacology 27:587-595
Zhang R, Wang Y, Zhang L, Zhang Z, Tsang W, Lu M, Zhang L, Chopp M (2002b) Sildenafi l
(Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 33:
2675-2680
Zhang HT, Zhao Y, Huang Y, Dorairaj NR, Chandler LJ, O'Donnell JM (2004) Inhibition of the
phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of
the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus. Neuropsycho-
pharmacology 29:1432-1439
Zhang HT, Huang Y, Suvarna NU, Deng C, Crissman AM, Hopper AT, De Vivo M, Rose GM,
O'Donnell JM (2005) Effects of the novel PDE4 inhibitors MEM1018 and MEM1091 on
memory in the radial-arm maze and inhibitory avoidance tests in rats. Psychopharmacology
179:613-619
Zhang L, Zhang Z, Zhang RL, Cui Y, LaPointe MC, Silver B, Chopp M (2006) Tadalafil,
a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional
recovery in a rat model of embolic stroke. Brain Res 1118:192-198
